Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

Novo Nordisk’s bid to provide a once-weekly ... Australia, Japan, and Switzerland under the Awiqli brand name, as well as in China. Eli Lilly is its nearest rival, developing a once-weekly ...

Novo Nordisk got the go-ahead for its once-daily ... and has also been given a green light in Australia, Japan, Switzerland, and the EU. Both are vying for market share with Roche's near $5 ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

As Sudan enters its third year of war, hunger has reached catastrophic levels. Famine has been confirmed in 10 areas, and 17 others are at risk. Millions of people like Abu Sufian and his family are ...

Amivantamab has been approved for the treatment of patients with advanced non–small-cell lung cancer (NSCLC) with epidermal ...

Opportunities lie in the launch of advanced autoinjectors with smart technology and favorable regulatory environments, ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity is now under attack on multiple fronts, from ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO – Research Report) and ...